Publication:
Atrophic enteropathy refractory to a gluten-free diet: what should we consider?

dc.contributor.authorMartín-Lagos Maldonado, Alicia
dc.contributor.authorGarcía-Consuegra Ruiz-Aragón, Fátima
dc.contributor.authorHerrera Mercader, Myriam Del Carmen
dc.date.accessioned2023-02-08T14:41:15Z
dc.date.available2023-02-08T14:41:15Z
dc.date.issued2020
dc.description.abstractOlmesartan is an angiotensin II receptor antagonist used for the treatment of blood hypertension. Long-term use has been associated with diarrhea and sometimes intestinal involvement may mimic enteropathies such as celiac disease. Clinicians should consider drugs within the differential diagnosis of enteropathies. We report the case of a female who sought medical help for malabsorptive symptoms and was finally diagnosed with olmesartan-associated gastritis and atrophic enteropathy.
dc.identifier.doi10.17235/reed.2020.6361/2019
dc.identifier.issn1130-0108
dc.identifier.pmid32054274
dc.identifier.unpaywallURLhttps://doi.org/10.17235/reed.2020.6361/2019
dc.identifier.urihttp://hdl.handle.net/10668/15101
dc.issue.number4
dc.journal.titleRevista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
dc.journal.titleabbreviationRev Esp Enferm Dig
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario San Cecilio
dc.page.number328-329
dc.pubmedtypeCase Reports
dc.pubmedtypeJournal Article
dc.rights.accessRightsopen access
dc.subject.meshCeliac Disease
dc.subject.meshDiarrhea
dc.subject.meshDiet, Gluten-Free
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshHypertension
dc.subject.meshIntestinal Diseases
dc.titleAtrophic enteropathy refractory to a gluten-free diet: what should we consider?
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number112
dspace.entity.typePublication

Files